(Beyond Pesticides, March 16, 2022) The U.S. Environmental Protection Agency has authorized the “experimental use” and release of 2.5 billion genetically engineered (GE) mosquitoes in Florida and California by the British-based firm Oxitec. While the goal of eliminating disease carrying mosquitoes is an important public health challenge, public opinion has been consistently against the use of these animals, with nearly 240,000 individuals opposing a pilot program in the Florida Keys. Health and environmental advocates have a range of concerns with Oxitec’s approach, including the size of its latest experiment, lack of publicly verifiable efficacy data, and availability of alternative management practices not requiring GE mosquitoes. Oxitec began public releases of its GE mosquitoes at least a decade ago, when mosquito larvae were introduced in the Brazilian town of Itaberaba. The company has consistently angled to launch its mosquitoes in the United States under the claim that the animals will reduce numbers of Aedes aegypti, a highly problematic mosquito known to vector a range of diseases, including dengue, yellow fever chikungunya, and Zika. Research analyzing Oxitec’s proposals note that the risk of dengue and other disease from Aedes aegypti is low in the United States. In a recent study in Globalization … Continue reading EPA Permits Experimental Release of 2.5 Billion Genetically Engineered Mosquitoes in California and Florida